The indication for primary prevention of sudden cardiac death in patients with HFimpEF is ambiguous, but ICD implantation should be considered in patients with an identified genetic cause of cardiomyopathy at high risk of ventricular arrhythmias (e.g., LMNA, SCN5A, FLNC). This evidence concerns the gene SCN5A and cardiomyopathy.